Jennifer Schranz, Chief Medical Officer at Nabriva Therapeutics plc (NBRV), bought 5,500 shares at $3.73 ($21K) on 2018-06-22, disclosed to the SEC on 2018-06-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.